Cytolytic Perforin as an Adjuvant to Enhance the Immunogenicity of DNA Vaccines

DNA vaccines present one of the most cost-effective platforms to develop global vaccines, which have been tested for nearly three decades in preclinical and clinical settings with some success in the clinic. However, one of the major challenges for the development of DNA vaccines is their poor immun...

Descripción completa

Detalles Bibliográficos
Autores principales: Shrestha, Ashish C., Wijesundara, Danushka K., Masavuli, Makutiro G., Mekonnen, Zelalem A., Gowans, Eric J., Grubor-Bauk, Branka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630607/
https://www.ncbi.nlm.nih.gov/pubmed/31052178
http://dx.doi.org/10.3390/vaccines7020038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6630607/
https://www.ncbi.nlm.nih.gov/pubmed/31052178
http://dx.doi.org/10.3390/vaccines7020038

Ejemplares similares